Home › Core › ISCC-IDs › 28C9fkiFBNVQX

View ISCC-ID

Core Data

28C9fkiFBNVQX
ISCC-ID - digital asset identifier
CCjAhJjU4fDXo-CTTpEDzCp9h9c-CDVF9zU6sTvM8-CRUvjGXvvCwhC
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 adx88178 in rodent models o

Ledger Reference

coblo
Source Ledger/Blockchain
10858
N-th ISCC Decleration on source ledger
02f45eae82c3d826203fa7a6e94e21f9823f374389d4d1880b0ca2d54fdff0d8
Hash of block that includes the ISCC-DECLARATION
7b4abe9e0aa7251b529cdee901f377536d7313f686ece25be70da29f80b6d5fb
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "M. Kalinichev", "@type": "Person"}, {"name": "E. Le Poul", "@type": "Person"}, {"name": "C. Bolea", "@type": "Person"}, {"name": "F. Girard", "@type": "Person"}, {"name": "B. Campo", "@type": "Person"}, {"name": "M. Fonsi", "@type": "Person"}, {"name": "I. Royer-Urios", "@type": "Person"}, {"name": "S. E. Browne", "@type": "Person"}, {"name": "J. M. Uslaner", "@type": "Person"}, {"name": "M. J. Davis", "@type": "Person"}, {"name": "J. Raber", "@type": "Person"}, {"name": "R. Duvoisin", "@type": "Person"}, {"name": "S. T. Bate", "@type": "Person"}, {"name": "I. J. Reynolds", "@type": "Person"}, {"name": "S. Poli", "@type": "Person"}, {"name": "S. Celanire", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4152882?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1124/jpet.114.214437", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCjAhJjU4fDXo-CTTpEDzCp9h9c-CDVF9zU6sTvM8-CRUvjGXvvCwhC", "propertyID": "ISCC"}], "datePublished": "2014-06-19"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close